Mechanism of Cannabidiol Effects on HIV Expression, Neuroinflammation, and HIV Cognitive Disease in Chronically-infected Immunocompetent Mice
大麻二酚对慢性感染免疫功能小鼠的 HIV 表达、神经炎症和 HIV 认知疾病的影响机制
基本信息
- 批准号:10448403
- 负责人:
- 金额:$ 72.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAnti-Inflammatory AgentsAnti-Retroviral AgentsAntigensAntiinflammatory EffectAnxietyApoptosisArchivesAstrocytesBasic ScienceBiochemicalBioinformaticsBiological AssayBrainBrain DiseasesCB2 knockoutCNR1 geneCNR2 geneCannabidiolCannabinoidsCannabisCell LineageCellsChronicCognition DisordersCritical PathwaysDNADetectionDiseaseDoseEpigenetic ProcessEvaluationFlow CytometryFrequenciesGene ExpressionGene Expression ProfilingGenesGenetic TranscriptionHIVHIV InfectionsHIV SeropositivityHypermethylationIL7 geneImmuneImmune responseImmune systemImmunityImmunocompetentImmunologicsImmunosuppressionImpaired cognitionImpairmentIn VitroIndividualInfectionInflammationInflammatoryInnate Immune ResponseInterferonsJointsKnockout MiceLearningLymphocyteMeasurementMediatingMicroRNAsMicrogliaModelingModificationMononuclearMusNational NeuroAids Tissue ConsortiumNeurocognitive DeficitNeuropathyPainPain-FreePathologyPathway interactionsPatientsPeripheralPeripheral Nervous System DiseasesPersonsPharmaceutical PreparationsPhosphorylationPoly I-CPopulationResearchResidual stateRoleRouteScienceSeminal fluidSignal PathwaySpecificityStimulusSystemSystems BiologyTestingTimeTissuesVirusadaptive immunityantagonistantiretroviral therapyantiviral immunitybehavior testbrain cellbrain dysfunctionbrain tissuechronic infectiondrug of abuseexperiencegene functionhigh riskhistone modificationin vivoinflammatory markermacrophagemarijuana usemarijuana userneuroinflammationpain reliefpre-clinicalpre-clinical researchprogramspromoterreceptorresponsesingle-cell RNA sequencingtranscriptometranscriptome sequencingtransmission process
项目摘要
This application is submitted in response to RFA-DA-20-022 and proposes basic
research
non-psychoactive
commonly experienced by PLWH. However, its long-term HIV infection and progression of HIV
disease remain largely undetermined. Our preliminary results in mice infected by chimeric HIV, EcoHIV, show
that CBD has both anti-inflammatory and immunosuppressive functions in the brain; strikingly the canonical
innate antiviral effector, interferon (IFN)-, was reduced in brains of infected CBD treated mice. Directly
relevant to this RFA, we show that CBD increases HIV expression in mouse brain up to 10-fold. Moreover,
despite anti-inflammatory effects of CBD alone, the drug failed to mitigate HIV mediated inflammatory gene
expression. These results suggest that CBD use can increase HIV expression in PLWH and thereby
exacerbate HIV-related diseases including NCI. We hypothesize that increased HIV brain infection by CBD
results from its impairment of antiviral immunity including IFN functions. The Specific Aims are to: 1)
Optimize CBD mediated increase in EcoHIV brain infection and assay its consequences in mouse behavioral
tests including responses in the presence of antiretroviral drugs and during chronic infection, tests of CB
receptor participation using knockout mice, and pilot HIV burden/ expression studies from brains of deceased
PLWH using cannabis. 2) Determine beneficial or deleterious effects of CBD on HIV control by immunity in
brains of EcoHIV-infected mice including assay of antigen-specific responses ex vivo, innate responses in vivo
and ex vivo, and gene expression profiling of brain lymphocyte, macrophage and microglia by single cell RNA-
seq and bioinformatics. 3) Using information from Aim 2, test the hypothesis that CBD increases HIV
expression in the brain and NCI by disruption of IFN responses including assay of post-transcriptional
modification in IFN induction, epigenetic modification in promoters of IFN stimulated genes, and IFN specificity
using knockout mice. Our approaches will include combined CBD and antiretroviral treatment of EcoHIV-
infected mice, QPCR for measurement of virus burden in tissues, behavioral tests of learning, isolation and
functional evaluation of mononuclear cells from the brain, brain cell lineage specific RNA seq, mechanistic
studies of CBD effects upon IFN signaling pathways and epigenetic changes determining IFN responsive gene
expression, key receptor knockout mice for responses to EcoHIV/CBD, and curated brain tissue from NNTC of
HIV-infected persons using cannabis and no other drugs of abuse. This application meets the RFA
requirements of “research models of chronic/persistent HIV-induced inflammation under conditions of ART”; for
evaluation of “the role of cannabinoids in HIV-associated chronic inflammation”; and to “Delineate ….. beneficial
or deleterious effects of cannabinoid use on HIV-induced inflammation”.
science and preclinical
in EcoHIV-infected mice to model cannabidiol (CBD) effects in people living with HIV (PLWH). CBD, a
cannabis component, is freely available and widely used for relieving pain and anxiety
effects on
本申请是根据RFA-DA-20-022提交的,并建议基本
研究
非精神活性
通常由PLWH经历。但是,其长期感染艾滋病病毒和艾滋病病毒的进展
疾病在很大程度上仍未确定。我们在感染嵌合HIV(EcoHIV)的小鼠中的初步结果显示,
CBD在大脑中具有抗炎和免疫抑制功能;引人注目的是,
先天性抗病毒效应物干扰素(IFN)-γ在受感染的CBD处理的小鼠的脑中减少。直接
与RFA相关,我们表明CBD使小鼠大脑中的HIV表达增加了10倍。此外,委员会认为,
尽管CBD单独具有抗炎作用,但该药物未能减轻HIV介导的炎症基因,
表情这些结果表明,CBD的使用可以增加艾滋病毒在PLWH中的表达,
加剧艾滋病毒相关疾病,包括NCI。我们假设CBD引起的HIV脑感染增加
结果是其损害了包括IFN功能在内的抗病毒免疫。具体目标是:1)
优化CBD介导的EcoHIV脑感染增加,并测定其对小鼠行为的影响
测试,包括在抗逆转录病毒药物的存在和慢性感染期间的反应,CB测试
使用基因敲除小鼠进行的受体参与研究,以及对死者大脑进行的HIV负荷/表达试验研究。
使用大麻的艾滋病毒携带者。2)确定CBD对艾滋病毒控制的有益或有害影响,通过免疫,
EcoHIV感染小鼠的脑,包括离体抗原特异性应答、体内先天性应答的测定
和离体,和脑淋巴细胞,巨噬细胞和小胶质细胞的基因表达谱通过单细胞RNA-
seq和生物信息学。3)使用目标2中的信息,测试CBD增加HIV的假设
通过干扰素应答的破坏在脑和NCI中的表达,包括转录后表达的测定。
IFN诱导中的修饰、IFN刺激基因启动子中的表观遗传修饰和IFN特异性
使用基因敲除小鼠。我们的方法将包括CBD和EcoHIV的抗逆转录病毒治疗相结合,
感染的小鼠,用于测量组织中病毒负荷的QPCR,学习、隔离和
来自脑的单核细胞的功能评价,脑细胞谱系特异性RNA测序,机制
CBD对IFN信号通路的影响及决定IFN应答基因的表观遗传学变化的研究
表达,关键受体敲除小鼠对EcoHIV/CBD的反应,以及来自NNTC的
使用大麻而不滥用其他药物的艾滋病毒感染者。此应用程序符合RFA
“ART条件下慢性/持续性HIV诱导炎症的研究模型”的要求;
评估“大麻素在艾滋病毒相关慢性炎症中的作用”;以及“描述.....有益
或大麻素使用对艾滋病毒引起的炎症的有害影响”。
科学和临床前
在EcoHIV感染的小鼠中模拟大麻二酚(CBD)对HIV感染者(PLWH)的影响。生物多样性公约a
大麻成分,是免费提供和广泛用于缓解疼痛和焦虑
影响
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alejandra Borjabad其他文献
Alejandra Borjabad的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alejandra Borjabad', 18)}}的其他基金
Mechanism of Cannabidiol Effects on HIV Expression, Neuroinflammation, and HIV Cognitive Disease in Chronically-infected Immunocompetent Mice
大麻二酚对慢性感染免疫功能小鼠的 HIV 表达、神经炎症和 HIV 认知疾病的影响机制
- 批准号:
10265583 - 财政年份:2020
- 资助金额:
$ 72.02万 - 项目类别:
Mechanism of Cannabidiol Effects on HIV Expression, Neuroinflammation, and HIV Cognitive Disease in Chronically-infected Immunocompetent Mice
大麻二酚对慢性感染免疫功能小鼠的 HIV 表达、神经炎症和 HIV 认知疾病的影响机制
- 批准号:
10686313 - 财政年份:2020
- 资助金额:
$ 72.02万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 72.02万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 72.02万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 72.02万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 72.02万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 72.02万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 72.02万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 72.02万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 72.02万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 72.02万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 72.02万 - 项目类别:














{{item.name}}会员




